Relationships between the presence of anti-Tat antibody, DNA and RNA viral load

New Microbiologica

Volumn 24, Issue 3, 2001, Pages 207-215

  Re, M C ^a   Gibellini, D ^a   Furlini, G ^a   Vignoli, M ^a   Vitone, F ^a   Bon, I ^a   La Placa, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; TRANSACTIVATOR PROTEIN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BLOOD; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; VIROLOGY; VIRUS LOAD;

ADULT; DNA, VIRAL; FEMALE; GENE PRODUCTS, TAT; HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; MALE; RNA, VIRAL; VIRAL LOAD;

EID: 0035409527     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ALBINI, A., SOLDI, R., GIUNCIUGLIO, D., GIRAUDO, E., BENELLI, R., PRIMO, L., NOONAN, D., SALIO, M., CAMUSSI, G., ROCKL, W., and BUSSOLINO, F. (1996). The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nature Medicine, 2, 1371-1375.
2. ALBINI, A, BENELLI, R., GIUNCIUGLIO, D., CAI, T., MARIANI, G., FERRINI, S., and NOONAN, D.M. (1998). Identification of a novel domain of HIV tat involved in monocyte chemotaxis. The Journal of Biological Chemistry, 273, 15895-15900.
3. BENELLI, R, MORTARINI, R., ANICHINI, A., GIUNCIUGLIO, D., NOONAN, D.M., MONTALTI, S., TACCHETTI, C., and ALBINI, A. (1998). Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides. AIDS, 12, 261-268.
4. BORGATTI, P, ZAULI, G., COLAMUSSI, M.L., GIBELLINI, D., PREVIATI, M., CANTLEY, L.L., and CAPITANI, S. (1997). Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. European Journal of Immunology, 11, 2805-2811.
5. CAFARO A, CAPUTO, A., FRACASSO, C., MAGGIORELLA, M.T., GOLETTI, D., BARONCELLI, S., PACE, M., SERNICOLA, L., KOANGA-MOGTOMO, M.L., BETTI, M., BORSETTI, A., BELLI, R., AKERBLOM, L., CORRIAS, F., BUTTO, S., HEENEY, J., VERANI, P., TITTI, F., and ENSOLI, B. (1999). Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nature Medicine, 6, 643-650.
6. COHEN, S.S., LI, C., DING, L., CAO, Y., PARDEE, A.B., SHEVACH, E.M., and COHEN, D.I. (1999). Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proceedings of the National Academy of Sciences USA, 19, 10842-10847.
7. CONANT, K, MA, M., NATH, A., and MAJOR, E.O. (1996). Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. Journal of Virology, 70, 1384-1389.
8. ENSOLI, B, BUONAGURO, L., BARILLARI, G., FIORELLI, V., GENDELMAN, R., MORGAN, R.A., WINGFIELD, P., and GALLO, R.C. (1993). Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. Journal of Virology, 1, 277-87.
9. FRANKEL, A.D., and YOUNG, Y.A. (1998). HIV-1, fifteen proteins and an RNA. Annual Review of Biochemstry, 67, 1-25.
10. GALLO, R.C. (1999). Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine. Proceedings of the National Academy of Sciences USA, 15, 8324-6.
11. GIBELLINI, D, CAPUTO, A., CAPITANI, S., LA PLACA, M., and ZAULI, G. (1997). Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein. Blood, 89, 1654-64.
12. GIBELLINI, D., BASSINI, A., PIERPAOLI, S., BERTOLASO, L., MILANI, D., CAPITANI, S., LA PLACA, M., and ZAULI, G. (1998). Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells. Journal of Immunology, 160, 3891-3898.
13. GIBELLINI, D., RE, M.C., MISCIA, S., LA PLACA, M., and ZAULI, G. (2000). Extracellular HIV-1 Tat protein activates the transcriptional reprossor ICER in both Jurkat cell line and primary peripheral blood mononuclear cells. AIDS, 14, 1059-1078.
14. GRINGERI, A., SANTAGOSTINO, E., MUCA-PERJA, M., MANNUCCI, P.M., ZAGURY, J.F., BIZZINI, B., LACHGAR, A., CARCAGNO, M., RAPPAPORT, J., CRISCUOLO, M., BLATTNER, W., BURNY, A., GALLO, R.C., and ZAGURY, D. (1998). Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. Journal of Human Virology, 1, 293-298.
15. GRINGERI, A., SANTAGOSTINO, E., MUCA-PERJA, M., LE BUANEC, H., BIZZINI, B., LACHGAR, A., ZAGURY, J.F., RAPPAPORT, J., BURNY, A., GALLO, R.C., and ZAGURY, D. (1999). Tat toxoid as a component of a preventive vaccine in seronegative subjects. Journal of AIDS, 4, 371-375.
16. JONES, K.A., and PETERLIN, B.M. (1994). Control of RNA initiation and elongation at the HIV-1 promoter. Annual Review of Biochemistry, 63, 717-43.
17. KUMAR, A., MANNA, S.K., DHAWAN, S., and AGGARWAL, B.B. (1998). HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. Journal of Immunlogy, 161, 776-81.
18. LAFRENIE, R.M., WAHL, L.M., EPSTEIN, J.S., HEWLETT, I.K., YAMADA, K.M., and DHAWAN, S. (1996). HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. Journal of Immunlogy, 157, 974-7.
19. LE BUANEC, H., LACHGAR, A., BIZZINI, B., ZAGURY, J.F., RAPPAPORT, J., SANTAGOSTINO, E., MUCA-PERJA, M., and GRINGERI, A. (1998). A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoid. Biomedicine and Pharmacotherapy, 52, 431-5.
20. LI, C.J., FRIEDMAN, D.J., WANG, C., METELEV, V., and PARDEE A.B. (1995). Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science, 5209, 429-31.
21. MCCLOSKEY, T.W., OTT, M., TRIBBLE, E., KHAN, S.A., TEICHBERG, S., PAUL, M.O., PAHWA, S., VERDIN, E., and CHIRMULE, N. (1997). Dual role of HIV Tat in regulation of apoptosis in T cells. Journal of Immunology, 158, 1014-9.
22. MILANI, D., MAZZONI, M., ZAULI, G., MISCHIATI, C., GIBELLINI, D., GIACCA, M., and CAPITANI, S. (1998). HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells. AIDS, 12, 1275-84.
23. MITOLA, S., SOZZANI, S., LUINI, W., PRIMO, L., BORSATTI, A., WEICH, H. and BUSSOLINO, F. (1997). Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood, 90, 1365-72.
24. RAMAZZOTTI, E., VIGNOLI, M., RE, M.C., FURLINI, G., and LA PLACA, M. (1996). Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein. AIDS, 5, 455-61.
25. RE, M.C., FURLINI, G.., VIGNOLI, M., RAMAZZOTTI, E., RODERIGO, G., DE ROSA, V., ZAULI, G., LOLLI, S., CAPITANI, S., and LA PLACA, M. (1995). Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. Journal of AIDS, 10, 408-416.
26. RE, M.C., FURLINI, G., VIGNOLI, M., RAMAZZOTTI, E., ZAULI, G., and LA PLACA, M. (1996). Antibody against human immunodeficiency virus type 1 (HIV-1) Tat protein may have influenced the progression of AIDS in HIV-1-infected hemophiliac patients. Clinical Diagnostic and Laboratory Immunology, 3, 230-2.
27. RE, M.C., VIGNOLI, M., FURLINI, G., GIBELLINI, D., COLANGELI, V., VITONE, F., and LA PLACA, M. (2001). Antibodies against full-length Tat protein and some low molecular weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients. Journal of Clinical Virology, 21, 81-89
28. RE, M.C., GIBELLINI, D., VITONE, F., and LA PLACA, M. (2001). Antibody to HIV-1 Tat protein, a key molecule in HIV-1 pathogenesis. (A brief review). The New Microbiologica, in press.
29. STEINAA, L., SORENSEN, A.M, NIELSEN, J.O, and HANSEN, J.E. (1994). Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Archives of Virology 139, 263-71.
30. RUBARTELLI, A, POGGI, A., SITIA, R., and ZOCCHI, M.R. (1998). HIV-I Tat, a polypeptide for all seasons. Immunology Today, 12, 543-545.
31. WANG, Z., MORRIS, G.F., REED, J.C,. KELLY, G.D., and MORRIS, C.B. (1999). Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein. Virology, 257, 502-510.
32. WESTENDORP, M.O., FRANK, R., OCHSENBAUER, C., STRICKER, K., DHEIN, J., WALCZAK, H., DEBATIN, K.M., and KRAMMER, P.H. (1995). Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature, 375, 497-500.
33. ZAGURY, J.F., SILL, A., BLATTNER, W., LACHGAR, A., LE BUANEC, H., RICHARDSON, M., RAPPAPORT, J., HENDEL, H., BIZZINI, B., GRINGERI, A., CARCAGNO, M., CRISCUOLO, M., BURNY, A., GALLO, R.C., and ZAGURY (1998). Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS, a rationale for the use of Tat toxoid as an HIV-1 vaccine. Journal of Human Virology, 1, 282-292.
34. ZAULI, G., GIBELLINI, D., MILANI, D., MAZZONI, M., BORGATTI, P., LA PLACA, M., and CAPITANI, S. (1993). Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Research, 19, 4481-5.
35. ZAULI, G., LA PLACA, M., VIGNOLI, M., RE, MC., GIBELLINI, D., FURLINI, G., MILANI, D., MARCHISIO, M., MAZZONI, M., and CAPITANI, M. (1995). An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. Journa of AIDS, 10, 306-316.
36. ZAULI, G., GIBELLINI, D., CAPUTO, A., BASSINI, A., NEGRINI, M., MONNE, M., MAZZONI, M., and CAPITANI, S. (1995). The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood, 86, 3823-3834.
37. ZAULI, G., GIBELLINI, D., CELEGHINI, C., MISCHIATI, C., BASSINI, A., and LA PLACA M. (1996). Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. Journal of Immunology, 5, 2216-24.